Walk/run 5k this weekend to support raising awareness and fundraise for SCAD. Register at join.vghfoundation.ca/campai…
Jacqueline Saw retweeted
Premenopausal women with ACS are often labeled “low risk.” The reality: rising MI rates, more delays and misdiagnoses, and worse outcomes vs men.
ACS in younger women is different and needs tailored care, earlier recognition, and equity in treatment.
ahajournals.org/doi/10.1161/…

ALT Screening • Use validated instruments to screen for depression and anxiety (eg, BDI-II, PHQ-9, GDS, HADS) • Optimal timing of screening is uncertain but could be conducted at intervals post-ACS • Consider referral to mental health care professional Diagnosis • Confirm diagnosis of depression or anxiety, or both, prior to initiating treatment Treatment • Use shared decision-making to inform treatment decision • CBT and antidepressant mediations (eg, SSRI) are options and may be used together for optimal effect Re-Assessment • Reassess depression or anxiety, or both, symptoms and necessity of continued treatment or modification to treatment plan
Jacqueline Saw retweeted
Privileged to take part in an outstanding #ACC26 session on #LAAO. A rigorous, balanced and forward-looking discussion of the latest evidence and the promise of next-generation devices. @ACCinTouch @DeeDeeWangMD @cellisvandyep @MarieF_Poulin @docsaw
@AGoldsweig
Jacqueline Saw retweeted
Congratulations Mme President @Drroxmehran
🎉🎊 💃
Looking forward to a year of many successes & growth under your leadership @ACCinTouch
We're thrilled to celebrate #TCT2026 Program Director, Dr. Roxana Mehran as she officially assumes the role of President of the American College of Cardiology at #ACC26! ✨
A visionary and trailblazer in #interventionalcardiology, Dr. Mehran's leadership and dedication to advancing cardiovascular care continue to inspire the global community. 🌎🫀
We couldn't be prouder of this well-deserved achievement and look forward to the extraordinary impact she will make in her new role.
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD
CHAMPION trial results. Watchman met noninferiority compared to DOAC for CV death, stroke and systemic embolization. And reduced the primary safety endpoint of non-procedural bleeding.
Jacqueline Saw retweeted
🔓 For a limited time until January 31, we are offering free promotional access to this new article in #CJC! 🌐
Intravenous thrombolysis in SCAD: insights from the Canadian SCAD Study ⬇️
onlinecjc.ca/article/S0828-2…
@vanscad @docsaw @CardioUBC
Jacqueline Saw retweeted
To date there has been no attempt to develop integrated management pathways for the diagnosis and management of premenopausal women presenting with ACS.
This statement discusses key considerations for invasive angiography, revascularization, and related procedures such as arterial access, intravascular imaging, left ventricular angiography, invasive physiology, and provocative testing.
✍🏼 @docsaw @EstherSHKimMD @JohnBlakeman_RN @hollandtamis @MonSangh @MirvatAlasnag
📷 Diagnosis and management of ACS in premenopausal women.
Jacqueline Saw retweeted
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and are and often under-recognized patient population; this paper discusses the unique numerous challenges associated with their care.
✍🏼 @docsaw @EstherSHKimMD @JohnBlakeman_RN @hollandtamis @MonSangh @MirvatAlasnag
New AHA scientific statement on ACS in Premenopausal Women
ahajournals.org/doi/10.1161/…






















